back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-02-10 17:23 Tx date 2025-02-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,350
+5,000 vol $3.07 each |
83,311 | |
| Filed 2025-02-10 17:23 Tx date 2025-02-07 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,700
+10,000 vol $3.47 each |
78,311 | |
| Filed 2024-11-21 16:00 Tx date 2024-11-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,719
+2,258 vol $2.09 each |
68,311 | |
| Filed 2024-11-21 15:59 Tx date 2024-11-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,258 vol |
32,000 | |
| Filed 2024-11-21 15:58 Tx date 2024-11-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-1,742 vol |
34,258 | |
| Filed 2024-11-20 16:28 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
58 - Expiration of rights
|
-62 vol |
11,738 | |
| Filed 2024-11-20 16:27 Tx date 2024-11-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+24,000 vol |
36,000 | |
| Filed 2024-08-27 08:18 Tx date 2024-08-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,416
+1,400 vol $2.44 each |
66,053 | |
| Filed 2024-08-27 08:18 Tx date 2024-08-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,805
+3,600 vol $2.45 each |
64,653 | |
| Filed 2024-08-21 16:39 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,103
+6,053 vol $2.33 each |
61,053 | |
| Filed 2024-08-21 16:38 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-4,753 vol |
11,800 | |
| Filed 2024-08-21 16:37 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-6,053 vol |
16,553 | |
| Filed 2024-07-02 08:58 Tx date 2024-06-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,750
+9,000 vol $1.75 each |
55,000 | |
| Filed 2024-07-02 08:58 Tx date 2024-06-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,470
+6,000 vol $1.75 each |
46,000 | |
| Filed 2024-06-28 10:53 Tx date 2024-06-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
12,000 | ||
| Filed 2024-06-28 10:53 Tx date 2024-06-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
22,606 | ||
| Filed 2024-06-28 10:53 Tx date 2024-06-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
| Filed 2024-06-28 08:27 Tx date 2024-06-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
40,000 |